GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (OTCPK:CASBF) » Definitions » Short-Term Debt

CASBF (CanSino Biologics) Short-Term Debt : $163.34 Mil (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Short-Term Debt?

CanSino Biologics's Short-Term Debt for the quarter that ended in Jun. 2024 was $163.34 Mil.

CanSino Biologics's quarterly Short-Term Debt declined from Dec. 2023 ($195.35 Mil) to Mar. 2024 ($132.62 Mil) but then increased from Mar. 2024 ($132.62 Mil) to Jun. 2024 ($163.34 Mil).

CanSino Biologics's annual Short-Term Debt declined from Dec. 2022 ($226.00 Mil) to Dec. 2023 ($195.35 Mil) and declined from Dec. 2023 ($195.35 Mil) to Dec. 2024 ($122.54 Mil).

CanSino Biologics Short-Term Debt Historical Data

The historical data trend for CanSino Biologics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Short-Term Debt Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only 6.14 169.69 226.00 195.35 122.54

CanSino Biologics Quarterly Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.81 195.35 132.62 163.34 122.54

CanSino Biologics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

CanSino Biologics Short-Term Debt Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CanSino Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (OTCPK:CASBF) » Definitions » Short-Term Debt
Comparable Companies
HKSE:00570 HKSE:02005 HKSE:01558 HKSE:02186 HKSE:00512 HKSE:01349 HKSE:03613 HKSE:01681 HKSE:02877 HKSE:00460 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
06185:Hong Kong CJH:Germany 688185:China
Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
Website
https://www.cansinotech.com
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.